Recent advances in adjuvant systemic treatment for breast cancer: all systems go!
نویسندگان
چکیده
منابع مشابه
The new millennium for adjuvant therapy in breast cancer.
The treatment of microscopic metastatic breast cancer with adjuvant systemic therapy has undergone significant changes in recent years. At the same time, our understanding of the biology of breast cancer has also improved, predominantly as a consequence of data obtained from cDNA microarrays. Breast cancer genomic analyses now suggest that current breast cancer systemic therapies have a profoun...
متن کاملRecent advances in adjuvant systemic therapy for early-stage breast cancer.
More than 429 000 European women are diagnosed with breast cancer annually [1]. The vast majority of women present with early-stage disease and receive adjuvant systemic therapy following surgical resection. Although rates of breast cancerrelated mortality have continued to decline in Europe since the early 1990s, many women diagnosed with early-stage breast cancer will die due to disease recur...
متن کاملAdvances in Neoadjuvant and Adjuvant Therapy for Breast Cancer
Systemic therapy for breast cancer is evolving rapidly. The medical treatment of cancer includes chemotherapy, endocrine therapy, and therapy with targeted biologic agents. In the past, a patient’s stage, based on tumor size and nodal involvement, would determine the recommendations for medical therapy, whereas now the biologic features of the tumor direct the treatment plan. As a result of adv...
متن کاملMatters of the heart: cardiac toxicity of adjuvant systemic therapy for early-stage breast cancer
Breast cancer remains the most common malignancy in women. Since the late 1980s, significant advances have been made in the treatment of this cancer. Those advances, particularly the ones in the adjuvant setting, have led to declines in the mortality associated with breast cancer. But another result has been treatments that are more complex and that potentially carry more toxicity. One key toxi...
متن کاملControversies in the therapy of early stage breast cancer.
Breast cancer is the most common malignancy among U.S. women, with more than 200,000 new cases diagnosed annually. In the U.S., mortality from breast cancer has declined in recent years as a result of more widespread screening, leading to earlier detection, as well as advances in the adjuvant treatment of early-stage disease. It is widely accepted that the appropriate use of adjuvant chemothera...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Current Oncology
دوره 13 شماره
صفحات -
تاریخ انتشار 2006